Shift to digital only and remote interactions was/is the only available option during the pandemic. I expect the new normal to be...

Launching in pandemic time requires bold moves, such as those taken by Esperion, Horizon, Eisai or Clarus: - remote interactions with...

Low cost and universally available steroid Dexamethasone shown to reduced Covid deaths by one-third in ventilated patients, and by one...

Orthopedic, Cardiac, Neuro surgeons expect 3/4 of elective procedures returning by September, survey says. This should help MedTech...

Following initial surge due to Covid-19, patients continue seeing doctors remotely because it's more convenient and faster than in...

Restarting elective procedures ? Medicare/Medicaid has released guidance: - continue preventing the spread of the virus - reduce...

Launching in post-Covid time requires creativity. For its new lip-filler, Galderma is providing digital materials for healthcare...

Excellent article by Herb Riband and Suzanne Wait on lessons learned for post-Covid 19 cancer care in Europe. Key highlights: - cancer...

ASCO meeting took place virtually this year due to Covid-19. But it didn't fall short of exciting announcements that will shape the...

Millions of treatments have been delayed during the pandemic. These are not going away and some will become major procedures. Pharma and...

Millions of elective surgery procedures were postponed due to Covid-19, creating a backlog that will take months to clear. One way of...

How should Medtech companies re-visit launch priorities in post-Covid world ? By focusing on those with compelling value proposition and...

Hospital & Health system survey give key insights for Pharma and Medtech business re-start : - elective procedure volumes will not return...

Pharma and MedTech need to anticipate healthcare restart timing and steps, and adapt customer engagement accordingly. US Hospital...

Up to 80% elective surgeries and even 40% of cancer related surgeries have been canceled or postponed worldiwde due to Covid-19. It could...

Many countries are hoping to minimize future Covid risks with contact-tracing apps on smartphones, used to track people who have been in...

Checkpoint inhibitors against PD-1, PD-L1, CTLA-4 are dramatically improving cancer treatment in defined patient sub-sets. Combining...

Beyond launch events and face-to-face push, how should Pharma & MedTech launch products in a post-Covid world ? Novartis has recently...

More than 50 Covid-19 candidate vaccines are in development across the biotech and pharma industry, and multiple approaches are being...

Despite dramatic impact during Covid19 outbreak, Pharma and MedTech are expected to be relatively protected on the long run, particularly...